NCT00047593

Brief Summary

The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after twelve months of treatment in Japanese subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jan 2000

Longer than P75 for phase_3

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2000

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

October 8, 2002

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 11, 2002

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2004

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2004

Completed
Last Updated

August 5, 2008

Status Verified

August 1, 2008

Enrollment Period

4.5 years

First QC Date

October 8, 2002

Last Update Submit

August 4, 2008

Conditions

Open-Angle GlaucomaOcular Hypertension

Keywords

open-angleglaucomaocularhypertensionPOAGIrisPigmentationJapanese

Interventions

IOP Lowering MedicationsDRUG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Adults of Japanese Ethnicity

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (3)

Unknown Facility

Los Angeles, California, United States

Location

Unknown Facility

San Francisco, California, United States

Location

Unknown Facility

Honolulu, Hawaii, United States

Location

MeSH Terms

Conditions

Glaucoma, Open-AngleOcular HypertensionGlaucomaHypertension

Condition Hierarchy (Ancestors)

Eye DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

October 8, 2002

First Posted

October 11, 2002

Study Start

January 1, 2000

Primary Completion

July 1, 2004

Study Completion

July 1, 2004

Last Updated

August 5, 2008

Record last verified: 2008-08

Locations

US(3)